Sponsor or institution
Clinical trials and research at Oncomatryx Biopharma S.L.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Oncomatryx Biopharma S.L. that are recruiting, at sites in 2 countries (most in Spain (2), United States (2)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
OMTX705 added to standard chemo with or without tislelizumab for advanced pancreatic cancer
This trial will try adding OMTX705 to gemcitabine/nab‑paclitaxel, with or without tislelizumab, to see if it is safe and might help people with advanced or metastatic pancreatic cancer.
-
Evaluating OMTX705 alone and with pembrolizumab for advanced solid tumors
This study is testing a new treatment called OMTX705, both alone and with another drug called pembrolizumab, to see if it can help people with advanced solid tumors that currently have no good treatment options.
Quick answers
How many clinical trials run by Oncomatryx Biopharma S.L. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Spain (2 trials), United States (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.